Journey Medical Corp

Journey Medical Corp 的所有者是 Fortress Biotech.

Fortress Biotech 是一家在股票代码 FBIO (US) 下上市的公司。

Fortress Biotech 拥有 4家子公司，其中包括 Avenue Therapeutics、Checkpoint Therapeutics 和 Journey Medical Corp。

他们在：

• 生物技术80%
• 药店20%

查看带有其 13 名主要高管的组织结构图

Journey Medical Corp 搜索最多的简介

• Claude Maraoui, Director, President and Chief Executive Officer
• Justin Smith, Director
• Miranda Toledano, Director

高管在Journey Medical Corp变化

• Jeffrey Paley, Director, 已经离开公司  (新闻发布的2023十二月11号).

创建提醒
跟踪 Journey Medical Corp 的高管变动

Fortress Biotech 拥有 1,867 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。

Popular M&A news in 药店

• AstraZeneca has announced the acquisition of Fusion Pharma  (公布2024三月23号).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (公布2024三月19号).
• Frontier Medicines 刚刚宣布为 80 筹款数百万美元。 (公布2024二月27号).

药店 行业的其他推荐联系人

• Ferring Pharmaceuticals 企业 Jean-Frédéric Paulsen - Executive Chairman of the Board
• Dirk Rossmann 企业 Alice Schardt-Rossmann - Managing Director
• Amolyt Pharma 企业 Thierry Abribat - Chief Executive Officer

了解更多有关药店行业的信息 >

Journey Medical Corp 的最新新闻稿

• Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
• Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
• Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
• Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
• Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
• Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
• Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
• Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
• Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea
• Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
• View more press releases Close

关于 Journey Medical Corp 的社交媒体

• Journey Medical Corp 在 维基百科、谷歌新闻 和 雅虎财经
• Journey Medical Corp 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Claude Maraoui

致电Journey Medical Corp，电话：+1 480...

查看组织结构图

Register to receive your alert

报告错误